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The C. elegans Protein EGL-1 Is Required
for Programmed Cell Death and Interacts
with the Bcl-2±like Protein CED-9
ces-1 and ces-2; these two genes specify the life-ver-
sus-death decisions of a subset of cells, including the
sisters of the NSM neurons in the pharynx (Ellis and
Horvitz, 1991).
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ced-4, and ced-3 may reflect direct physical interactions
of the protein products of these genes. The CED-9 pro-
tein binds to the CED-4 protein (Chinnaiyan et al., 1997a;Summary
James et al., 1997; Ottilie et al., 1997a; Spector et al.,
1997; Wu et al., 1997a), which in turn can bind to theGain-of-function mutations in the Caenorhabditis ele-
CED-3 protein (Chinnaiyan et al., 1997a; Wu et al.,gans gene egl-1 cause the HSN neurons to undergo
1997b). Furthermore, the interaction of CED-4 with CED-3programmed cell death. By contrast, a loss-of-func-
appears to lead to the activation of CED-3 and the initia-tion egl-1 mutation prevents most if not all somatic
tion of cell death (Chinnaiyan et al., 1997b; Seshagiriprogrammed cell deaths. The egl-1 gene negatively
and Miller, 1997; Wu et al., 1997b).regulates the ced-9 gene, which protects against cell
ced-9, ced-4, and ced-3 have mammalian counter-death and is a member of the bcl-2 family. The EGL-1
parts also shown to be involved in programmed cellprotein contains a nine amino acid region similar to
death. ced-9 encodes a protein structurally and func-the Bcl-2 homology region 3 (BH3) domain but does
tionally similar to the mammalian cell death inhibitornot contain a BH1, BH2, or BH4 domain, suggesting
Bcl-2 (Hengartner and Horvitz, 1994b), the prototype ofthat EGL-1 may be a member of a family of cell death
a family of Bcl-2±like molecules that act as regulatorsactivators that includes the mammalian proteins Bik,
of cell death in mammals (reviewed by White, 1996;Bid, Harakiri, and Bad. The EGL-1 and CED-9 proteins
Rinkenberger and Korsmeyer, 1997). CED-3 is a memberinteract physically. We propose that EGL-1 activates
of a family of invertebrate and mammalian cysteine pro-programmed cell death by binding to and directly in-
teases, collectively called caspases, that are cell deathhibiting the activity of CED-9, perhaps by releasing the
effectors acting mainly downstream of Bcl-2±like cellcell death activator CED-4 from a CED-9/CED-4±con-
death regulators (reviewed by Fraser and Evan, 1996;taining protein complex.
Nicholson and Thornberry, 1997). Finally, Apaf-1, a
mammalian protein recently identified biochemically asIntroduction
essential for caspase-3 activation in an in vitro assay
for programmed cell death (Zhou et al., 1997), is in partProgrammed cell death is a physiological process that
similar in sequence to the CED-4 protein (Yuan andhas beenconserved through evolution (Ellis et al., 1991a;
Horvitz, 1992).Raff, 1992). Genetic analyses of the cell death process in
Recently, a new group of mammalian cell death activa-
Caenorhabditis elegans have defined a genetic pathway
tors has been identified. These proteins, which include
for programmed cell death (reviewed by Horvitz et al.,
Bik, Bid, Harakiri, and Bad, interact with Bcl-2±like pro-
1994). Mutations in three genes, ced-9, ced-4, and ced-3
teins and can induce cell death when overexpressed
(ced, cell-death abnormal), affect most if not all of the
(Boyd et al., 1995; Yang et al., 1995; Han et al., 1996a;
131 somatic cell deaths that occur during the develop-
Wang et al., 1996; Inohara et al., 1997; Kelekar et al.,
ment of the C. elegans hermaphrodite (Sulston and Hor-
1997; Ottilie et al., 1997b; Zha et al., 1997). The amino
vitz, 1977; Sulston et al., 1983). Loss-of-function (lf) mu- acid sequences of these cell death activators are dissim-
tations in ced-3 or ced-4 result in the survival of cells that
ilar, except for a nine amino acid stretch similar to one of
normally die, indicating that these genes are required for
the four Bcl-2 homology (BH) domains, the BH3 domain,
the killing process (Ellis and Horvitz, 1986). ced-9, by
and particularly similar to the BH3 domain of the Bcl-2±
contrast, is a negative regulator of programmed cell like cell death activators Bax and Bak (Chittenden et al.,
death. A gain-of-function (gf) mutation in ced-9 prevents 1995; Han et al., 1996b; Hunter and Parslow, 1996; Zha
most, if not all, programmed celldeaths, and lf mutations et al., 1996). As in the cases of Bax and Bak (Chittenden
in ced-9 cause embryonic lethality as a consequence et al., 1995; Han et al., 1996b), the BH3 domains of this
of ectopic cell death (Hengartner et al.,1992). This lethal- new group of cell death activators are important both
ity is suppressed by lf mutations in ced-3 or ced-4, for their interaction with Bcl-2±like molecules and for
indicating that ced-3 and ced-4 act downstream of or their ability to induce cell death (Wang et al., 1996; Ino-
in parallel to ced-9 (Hengartner et al., 1992). ced-4 is hara et al., 1997; Kelekar et al., 1997; Ottilie et al., 1997b;
likely to act upstream of ced-3, since cell death induced Zha et al., 1997).
by ced-4 overexpression is greatly reduced in the ab- In this paper, we report that the C. elegans gene egl-1
sence of ced-3 activity (Shaham and Horvitz, 1996a). The (egl, egg-laying defective) encodes a protein that inter-
ced-9, ced-4, and ced-3 central cell death machinery is acts with CED-9 and contains a region similar to the
thought to be regulated by cell type±specific regulators, BH3 domains of BH3-containing cell death activators.
which include the cell death specification or ces genes gf mutations in egl-1 cause the two hermaphrodite-spe-
cific neurons (HSNs), which are required for egg lay-
ing, to undergo programmed cell death inappropriately;*To whom correspondence should be addressed.
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Table 1. n3082 Blocks Programmed Cell Deaths
% Egg-Laying Defective % HSNs Surviving No. Extra Cells/ Pharynxa
Genotype (n) n 5 40 n 5 15
N2 1 (248) 100 0.0 6 0.0
egl-1(n1084) 99 (166) 0 0.0 6 0.3
egl-1(n1084)/1 71 (238) 27 ND
nDf42/1 1 (108) 92 0.9 6 0.7
egl-1(n1084)/nDf42 68 (165) 42 ND
egl-1(n1084 n3082) 0 (113) 97 11.1 6 1.5
egl-1(n1084 n3082)/egl-1(n1084) 66 (423) 30 ND
egl-1(n1084 n3082)/1 0 (256) 98 1.0 6 1.5
egl-1(n1084 n3082)/nDf42 1 (88) 100 11.5 6 1.5
The Egl phenotype and the presence of HSNs and extra cells in the anterior pharynx were scored as described in Experimental Procedures.
The complete genotypes of the animals scored were, from top to bottom, as follows: N2 (wild-type), egl-1(n1084), egl-1(n1084) unc-76(e911)/
11, nDf42/1, egl-1(n1084)/nDf42, egl-1(n1084 n3082), egl-1(n1084) unc-76(e911)/egl-1(n1084 n3082), egl-1(n1084 n3082)/unc-42(e270) for
the egg-laying phenotype and egl-1(n1084 n3082)/unc-76(e911) for the HSN and extra cells phenotype, egl-1(n1084 n3082)/nDf42. For compari-
son, ced-3(n717) animals have 10.7 6 1.7 (n 5 15), ced-4(n1162) animals 10.2 6 1.5 (n 5 15), and ced-9(n1950) animals 12.4 6 1.9 (n 5 15)
extra cells in the anterior pharynx. ND, not determined.
a Numbers represent averages 6 standard deviations.
these mutations were identified inscreens for egg-laying seven mutations were not necessarily independent in
origin, and all seven carry the same 5 bp deletion (seedefective (Egl) mutants (Trent et al., 1983). By isolating
a dominant suppressor of the egl-1 Egl phenotype, we below). We assume that they derived from a single, pos-
sibly spontaneous, deletion event. The data presentedidentified an lf mutation in the egl-1 gene. This mutation
prevents not only the ectopic deaths of the HSNs but below were therefore obtained from one representative
isolate, which carries the allele n3082.most if not all normally occurring programmed cell
deaths, indicating that egl-1 is a cell death activator The n3082 mutation is a semidominant suppressor of
egl-1(n1084): while 0% of hermaphrodites homozygousand encodes a component of the general cell death
machinery in C. elegans. for egl-1(n1084 n3082) are Egl, 66% of hermaphro-
dites homozygous for egl-1(n1084) but heterozygous for
n3082 (i.e., of genotype egl-1[n1084 n3082]/egl-1[n1084])Results
are Egl (Table 1). Microscopic analyses using Nomarski
optics revealed that the HSN neurons are present inAn lf Mutation in egl-1 Blocks Programmed
Cell Death egl-1(n1084 n3082) hermaphrodites, suggesting that the
suppression of the Egl phenotype is caused by the sup-Dominant mutations in the gene egl-1 cause the HSNs
to undergo programmed cell death (Trent et al., 1983; pression of the deaths of the HSNs (Table 1).
To determine the effect of the n3082 mutation on cellsEllis and Horvitz, 1986). This ectopic cell death results
in an Egl phenotype, as exemplified for the egl-1 allele that normally undergo programmed cell death in C. ele-
gans, we determined the number of cells in the anteriorn1084 in Table 1. Hermaphrodites heterozygous for
nDf42, a deficiency that deletes the egl-1 locus, do not pharynx of egl-1(n1084 n3082) animals at the third
stage of larval development. Mutations that block pro-exhibit an Egl phenotype (Horvitz et al., 1994) (Table 1),
indicating that the dominant mutations in egl-1 are not grammed cell death in C. elegans, such as a gf mutation
in ced-9 or lf mutations in ced-4 or ced-3, result in thenull mutations but rather are likely to be gf mutations.
To date, seven egl-1(gf) mutations have been identified presence of 11±12 extra cells in the anterior pharynx
(Hengartner et al., 1992). egl-1(n1084 n3082) animals(Trent et al., 1983; Desai and Horvitz, 1989; Horvitz et
al., unpublished data). had on average 11.1 extra cells in the anterior pharynx
(Table 1). This result indicates that the n3082 mutationTo determine the lf phenotype of egl-1, we performed
a screen for dominant suppressors of the egl-1 Egl phe- not only blocks the ectopic deaths of the HSNs in
egl-1(n1084) animals but, like the ced-9(gf), ced-4(lf),notype. Specifically, hermaphrodites homozygous for
the mutation egl-1(n1084) were mutagenized with ethyl and ced-3(lf) mutations, also causes a general block in
programmed cell death, that is, a Ced phenotype.methanesulfonate (EMS), allowed to self-fertilize, and
their F1 progeny were screened for rarenon-Egl animals. This conclusion was supported by our analysis of
egl-1(n1084 n3082) embryos for the presence of cellSince 68% of egl-1(n1084)/nDf42 heterozygous her-
maphrodites were Egl (Table 1), we reasoned that if one corpses in an engulfment-defective mutant background:
a ced-1 mutation blocks the engulfment of the cellcopy of the egl-1 gene in an egl-1(n1084) hermaphrodite
were inactivated by an egl-1 lf mutation, the resulting corpsesgenerated by programmedcell death and there-
fore allows a quantitative assessment of the number ofanimal should have about a one-third probability of be-
ing non-Egl. We analyzed 30,000 mutagenized haploid programmed cell deaths that have occurred as of a
particular stage of development (Ellis et al., 1991b). Em-genomes and isolated seven allelic suppressors that are
closely linked to the egl-1 locus on chromosome V. All bryos homozygous for ced-1 or for ced-1; egl-1(n1084)
had on average a total of 24.9 (n 5 15) and 24.1 (n 5seven suppressor mutations proved tobe alleles of egl-1
(B. C. and H. R. H., unpublished data) and therefore 15) corpses at the 1 1/2-fold stage of embryogenesis,
respectively. Homozygous ced-1; egl-1(n1084 n3082)represent intragenic revertants in the egl-1 gene. The
Programmed Cell Death Activator EGL-1
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Figure 1. Localization of the egl-1 Locus
(A) (Top) Genetic map. Genes and polymor-
phisms used for mapping the egl-1 locus are
indicated. Numbers below the genetic map
representthe fraction of the 76recombination
events identified between rol-4 and unc-76
that occurred between particular loci. (Mid-
dle) Physical map of the interval between
nP88 and stP6. Cosmids tested for rescue
are shown. The cosmids that detected nP88
(T20C8) and stP6 (KR#82), as well as the two
rescuing cosmids (C01G9 and C03B12), are
labeled.
(Bottom) Partial restriction map of the right
end of cosmid C01G9 and egl-1 rescue data
obtained with various subclones. Transgenic
animals carrying the indicated constructs as
extrachromosomal arrays were generated,
and rescue was scored as described in Ex-
perimental Procedures. The numbers of lines
rescued and the total number of lines ob-
tained are indicated in parentheses. The aver-
age numbers of corpses scored and the
range of corpses (parentheses) for one repre-
sentative line are also indicated (n 5 15).
(B) Structure of the full-length egl-1 transcript
as determined by cDNA cloning, RT-PCR,
and RACE. Coding exons are shaded. The
direction of the gene is indicated by its 59 and
39 ends. (Note that the orientation of the egl-1
locus has been reversed in [B]).
embryos, by contrast, contained only 0.1 corpses (n 5 into egl-1(n1084 n3082) animals by germline transforma-
tion (Mello and Fire, 1995) and tested for their ability to10) on average at this developmental stage.
The Ced phenotype of egl-1(n1084 n3082) animals is rescue the Ced phenotype. Rescue was assayed by
analyzing transgenic animals for the presence of cellrecessive:egl-1(n1084 n3082)/1 heterozygotes had only
1.0 extra cell (n 5 15) on average in the anterior pharynx corpses in embryos at the 1 1/2-fold stage of em-
bryogenesis. To increase the sensitivity of the assay,(Table 1). In addition, the Ced phenotype of animals
heterozygous for egl-1(n1084 n3082) and nDf42 (i.e., of the transgenic lines were established in a ced-1 mutant
background to allow the persistence of cell corpses.genotype egl-1[n1084 n3082]/nDf42) was indistinguish-
able from that of egl-1(n1084 n3082) animals (Table 1), Two overlapping cosmids, C01G9 and C03B12, both
almost completely rescued the Ced phenotype causedsuggesting that egl-1(n1084 n3082) is a strong lf allele
and that egl-1 is required for programmed cell death in by the n1084 n3082 allele (as many as an average of
23.4 corpses in embryos; n 5 15). We narrowed thissomatic tissues of C. elegans. Interestingly, cell death
in the C. elegans germline did not seem to be affected rescuing activity to a 7.8 kb subclone of C01G9 con-
tained in plasmid pBC08 (21.2 corpses; n 5 15) (Figureby the egl-1(n1084 n3082) mutation (our unpublished
observations). 1A). A 2.5 kb subclone of pBC08, pBC11, also rescued
the Ced phenotype but much less efficiently (1.5 corpses
on average with a range of 0±11). Additional deletionsCloning of egl-1
completely abolished the residual rescuing activity (Fig-To determine the molecular identity of egl-1, we cloned
ure 1A).the gene by transformation rescue of the recessive Ced
Using this minimal rescuing fragment as a probe, wephenotype of egl-1(n1084 n3082) homozygotes. First,
screened an embryonic cDNA library and isolated twowe used the Ced phenotype to map egl-1(n1084 n3082)
clones. The same probe detected a single approximatelyto the right arm of chromosome V between rol-4 and
650 bp message of low abundance in poly(A)1 mRNAunc-76 (data not shown), the interval to which egl-1(gf)
isolated from embryos and L1 larvae but not from latermutations were mapped previously (Trent et al., 1983;
larval stages or young adults (data not shown). UsingDesai and Horvitz, 1989). We further mapped egl-1(n1084
reverse transcriptase-polymerase chain reaction (RT-n3082) between the restriction fragment length polymor-
PCR) and anchored reverse-transcriptase PCR (RACE;phisms (RFLPs) nP88 on cosmid T20C8 and stP6 on
rapid amplification of cDNA ends), we determined thecosmid KR#82 (Williams et al., 1992) (Figure 1A). Cos-
mids that map between nP88 and stP6 were introduced complete structure and sequence of the transcript,
Cell
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Figure 2. egl-1 Sequence
(A) Sequences of the complete egl-1 tran-
script and protein product. Amino acids
underlined (58 to 66) constitute the BH3-like
region. The five nucleotides deleted by the
n3082 mutation are indicated by the hori-
zontal bar.
(B) Alignment of the EGL-1 BH3-like region
with the BH3 domains of BH3-containing pro-
teins (human Bik, accession number U34584;
mouse Bid, U75506; human Harakiri, U76376;
and mouse Bad, L37296) and the Bcl-2-like
proteins Bak and Bax (human Bak, U23765;
human Bax, L22474). Amino acids that are
identical in at least four of the seven se-
quences and conserved amino acids are
shaded in dark and light grey, respectively.
which has two coding exons and two potential initiator unpublished observations). The truncated EGL-1 protein
predicted to be formed in egl-1(n1084 n3082) animalscodons, of which we predict the more 39 ATG to be
used in vivo (Figure 1B and Figure 2A, data not shown). lacks thisBH3-like regionand the Cterminusof theprotein.
Frameshift mutations introduced into the genomic frag-
ment contained in pBC13 confirmed that this transcript egl-1 Null Phenotype
was responsible for the rescuing activity (data not The observation that animals homozygous for egl-1(n1084
shown). Furthermore, the expression of the predicted n3082) have the same number of extra cells in the ante-
coding region under the control of a C. elegans heat- rior pharynx as animals trans-heterozygous for egl-
shock promoter (Phsp;Mello and Fire, 1995) was sufficient 1(n1084 n3082) and nDf42 (Table 1) suggests that the
to rescue the Ced phenotype of ced-1; egl-1(n1084 n3082 mutation results in at least a severe loss of the
n3082) animals. Transgenic ced-1; egl-1(n1084 n3082) normal function of the EGL-1 protein. Furthermore, oth-
embryos carrying extrachromosomal arrays containing ers have observed that embryos homozygous for defi-
the Phsp egl-1 construct contained up to 31.9 corpses ciencies that uncover loci to the left and right of the
on average at the 1 1/2-fold stage after being subjected egl-1 locus, and therefore that presumably delete egl-1,
to heat shock (Table 2). lack cell corpses (J. Rothman, personal communication)
To confirm that the identified gene is egl-1, we deter- and contain up to 40% more nuclei than do wild-type
mined the nucleotide sequence of the gene for each embryos (M. Labouesse, personal communication), indi-
of the seven egl-1(gf) suppressors we had isolated. All cating that a total loss of the egl-1 region results in a
seven alleles had an identical 5 bp deletion at the begin- block in programmed cell death. We have observed that
ning of exon 2 (Figure 2A). This deletion is predicted
to result in a frameshift leading to the generation of a
truncated protein composed of the first half of the wild- Table 2. An egl-1 cDNA Expressed under the Control of a C.
type protein (45 amino acids) and a 16 amino acid C-ter- elegans Heat-Shock Promoter Rescued the Ced Phenotype
minal extension in a different reading frame. of n3082 Animals
Number of Corpses (Range)
egl-1 Encodes a Novel Protein with a Nine Amino
Transgene Line Mock Heat ShockAcid Region Similar to the BH3 Domain of
Bcl-2±like and BH3-Containing Proteins Phsp A 0.0 0.0
Phsp B 0.0 0.0Searches of current nucleotide and protein databases us-
Phsp egl-1 A 0.3 (0±1) 30.8 (19±45)ing various BLAST programs identified no known se-
Phsp egl-1 B 0.1 (0±1) 31.9 (20±42)quences or proteins with significant similarity to the egl-1
Phsp egl-1 C 0.1 (0±1) 26.2 (17±40)gene or the EGL-1 protein. egl-1 therefore encodesa novel Phsp egl-1 D 0.3 (0±1) 28.6 (17±43)
protein of 91 amino acids with no apparent hydrophobic
Transgenic animals were generated as described in Experimentalstretches indicative of transmembrane domains (Figure
Procedures. Different lines carried independently derived extrachro-
2A). Closer inspection of the EGL-1 sequence revealed a mosomal arrays of Phsp (Phsp A and B) or the Phsp egl-1 transgene
stretch of nine amino acids in the center of the protein (Phsp eg1-1 A±D). Heat shock was performed as follows. Transgenic
(amino acids 58 to 66) with similarity to the BH3 domain adults were allowed to lay eggs for 1 hr and then were removed
from the plate. The eggs were heat-shocked at 338C for 45 min andof the family of Bcl-2±like and BH3-containing proteins
scored for rescue at the 1 1/2-fold stage of embryogenesis. Data(Figure 2B). Like the BH3 domain of Bcl-2±like and BH3-
presented are averages and ranges of the number of cell corpses.containing proteins, the BH3-like region of EGL-1 is pre-
For each experiment, 10±15 animals were scored.
dicted toadopt the structure of anamphipathic a-helix (our
Programmed Cell Death Activator EGL-1
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Table 4. egl-1±Induced Ectopic Killing Is Suppressed byTable 3. n3082 Is Epistatic to an lf Mutation in the Cell
Death±Specification Gene ces-1 Mutations that Block Programmed Cell Death
% NSM Sister Survival % ALMs Surviving
Transgene (n 5 60)Strain (n 5 50)
Pmec-7 A 98ces-1 (lf) 0
egl-1 (n1084 n3082) 88 Pmec-7 B 100
Pmec-7 egl-1 A 8ces-1 (lf); egl-1 (n1084 n3082) 86
Pmec-7 egl-1 B 9NSM sister cells were scored as described in Experimental Proce- Pmec-7 egl-1 C 10dures. The ces-1 (lf) mutation used was ces-1(n703 n1434). Pmec-7 egl-1C/1 50
Pmec-7 egl-1 C; ced-9 (gf) 98
Pmec-7 egl-1 C; ced-4 (lf) 97
Pmec-7 egl-1 C; ced-3 (lf) 98embryos homozygous for deficiencies that fail to com-
Transgenic animals were generated and ALMs in transgenic L1 lar-plement egl-1(n1084 n3082), such as nDf42, yDf8, zuDf2,
vae scored as described in Experimental Procedures. Control linesand itDf2, lack cell corpses at the comma stage of em-
Pmec-7 A and B contained extrachromosomal arrays of Pmec-7, andbryogenesis (n 5 10±15) (a stage of development at
experimental lines contained Pmec-7 egl-1 A±C integrated arrays ofwhich wild-type embryos have an average of about six the transgene Pmec-7 egl-1. Mutations used were as follows: ced-9
corpses; n 5 10) and therefore are cell death defective. (gf) was ced-9(n1950), ced-4 (lf) was ced-4(n1162), and ced-3 (lf)
was ced-3(n717).By contrast, embryos homozygous for deficiencies that
delete regions to the left or right of the egl-1 locus, such
as lwDf3 or yDf11, have an average of 8.3 (n 5 10) and
5.2 (n 5 10) corpses, respectively. These observations egl-1 (Pmec-7 egl-1 A-C), only about 10% of the ALM neu-
rons were present (Table 4). Bycontrast, almost all ALMsare consistent with the hypothesis that the complete
inactivation of the egl-1 locus results in a block in pro- survived in animals either carrying an extrachromosomal
array with the Pmec-7 vector (Table 4, Pmec-7 A and B) orgrammed cell death. However, since nDf42, yDf8, zuDf2,
and itDf2 cause not only a Ced phenotype but also homozygous for an integrated Pmec-7 lacZ fusion con-
struct (Shaham and Horvitz, 1996a). The egl-1±inducedembryonic lethality, it is possible that egl-1(n1084 n3082)
is not a null mutation and that a null allele of egl-1 would killing of the ALMs was dependent on the number of
copies of the egl-1 gene: 50% of the ALMs survived inresult in some additional phenotypic abnormality, such
as embryonic lethality. animals heterozygous for Pmec-7 egl-1 C (Pmec-7 egl-1 C/1).
egl-1±induced killing was completely blocked by lf mu-
tations in ced-4 or ced-3 (Table 4), confirming that egl-egl-1 Acts Downstream of or in Parallel
to the Genes Involved in Cell 1±induced killing involved the knowncell death pathway.
That egl-1 required the activities of ced-3 and ced-4 toDeath Specification
To determine at what stage in the well characterized induce killing indicates that egl-1 functions upstream of
or in parallel to ced-4 and ced-3. This conclusion isC. elegans genetic pathway for programmed cell death
egl-1 acts, we performed epistasis analysis. We first supported by the observation that the egl-1(gf) pheno-
type, the ectopic deaths of theHSN neurons in hermaph-constructed double mutants between egl-1 and the cell
death±specification gene ces-1, which acts downstream rodites, is suppressed by lf mutations in either ced-4 or
ced-3 (Trent et al., 1983; Ellis and Horvitz, 1986).of the cell death±specification gene ces-2 (Ellis and Hor-
vitz, 1991). In animals carrying an lf mutation in ces-1,
the sisters of the NSM neurons in the pharynx undergo egl-1 Functions through ced-9
The lethality caused by lf mutations in the cell death inhib-programmed cell death (Ellis and Horvitz, 1991); these
cells survive in egl-1(n1084 n3082) animals (Table 3). itor gene ced-9 is suppressed by lf mutations in either
ced-4 or ced-3, genes thought to act downstream ofWe found that the NSM sisters also survived in ces-1(lf);
egl-1(n1084 n3082) double mutant animals, indicating ced-9. To determine where egl-1 acts with respect to
ced-9, we tested the viability of a ced-9(lf); egl-1(n1084that the egl-1(n1084 n3082) allele is epistatic to the ces-
1(lf) mutation and suggesting that egl-1 acts down- n3082) double mutant strain. We found that this strain
was inviable, indicating that an egl-1(lf) mutation did notstream of or in parallel to ces-1.
suppress ced-9(lf)±induced lethality. egl-1 is therefore
likely to act upstream of or in parallel to ced-9. egl-1±egl-1 Acts Upstream of or in Parallel
to ced-4 and ced-3 induced killing of the ALM neurons (see above) was
suppressed by the ced-9 gf mutation n1950 (Table 4),Pmec-7 is a C. elegans promoter that becomes activated
in a small number of cells, including the six touch cells, supporting this conclusion.
To characterize the role of ced-9 in egl-1±induced cellneurons involved in mechanosensation (Hamelin et al.,
1992). Like ced-3 or ced-4 cDNAs (Shaham and Horvitz, killing in more detail, we tested whether the block in cell
death caused by theegl-1(n1084 n3082) allele is affected1996a), an egl-1 cDNA expressed under the control of
Pmec-7 can induce the C. elegans touch cells (including by a ced-9(lf) mutation. If egl-1 acts through ced-9, the
egl-1(n1084 n3082) mutation should prevent cell deaththe ALM neurons), which normally survive, to undergo
programmed cell death (Table 4). We used this ectopic only in the presence of a functional ced-9 gene. On the
other hand, if egl-1 acts in parallel to ced-9, a ced-9killing to determine the stage at which egl-1 acts with
respect to ced-4 and ced-3. (lf) mutation might not affect the ability of egl-1(n1084
n3082) to block cell death.In animals homozygous for integrated arrays of Pmec-7
Cell
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Because a ced-9 null mutation, ced-9(0), is lethal (in
both an egl-1[1] and egl-1[n1084 n3082] background),
we could not directly compare the effects of a ced-9(0)
mutation on cell death in egl-1(1) and egl-1(n1084
n3082) animals. Instead, we did this comparison in the
background of the weak ced-3 lf mutation n2427, which
suppresses the lethality of a ced-9(0) mutation. The
ced-3(n2427) mutation weakly inhibits programmed cell
death and resulted in 1.6 6 0.8 (average 6 standard
deviation, n 5 15) extra cells in the anterior pharynx. In
the background of the ced-3(n2427) mutation, as in a
ced-3(1) background, the egl-1(n1084 n3082) allele re-
sulted in 11.1 6 1.7 extra cells (n 5 15). Using a ced-9(0);
ced-3(n2427) double mutant background, we assessed
the death-inducing activity of egl-1 in the absence of
ced-9 function. ced-9(0); ced-3(n2427) animals carrying
the egl-1(1) allele had an average of 6.3 6 2.9 extra
cells in the anterior pharynx (n 5 15). Mutant animals
additionally carrying the egl-1(n1084 n3082) allele had
an average of 7.0 6 1.5 extra cells (n 5 15). Thus, the
presence of egl-1 activity did not affect programmed
Figure 3. EGL-1 and CED-9 Interactionscell death in a ced-9(0) animal, indicating that ced-9
(A) Wild-type CED-9 and EGL-1 proteins interact in vitro. 35S-labeledmust be functional for egl-1 to exert its effect on pro-
S´TAG-EGL-1 (lanes 1 and 5; 14.5 kDa), S´TAG alone (lanes 2 andgrammed cell death and hence that egl-1 acts upstream
6; 6.7 kDa), luciferase (lanes 3 and 7; 61 kDa), or SSN6 (lanes 4 and
of ced-9. 8; 107 kDa) were incubated with GST-CED-9 (lanes 1±4; 60 kDa) or
In the ced-3(n2427) background, ced-9(1) animals GST alone (lanes 5±8; 27 kDa) and analyzed for binding by SDS-
had 1.6 6 0.8 extra cells, and ced-9(0) animals had 6.3 6 PAGE and autoradiography as described in Experimental Proce-
dures. Lanes 9±12 represent 10% of the input of S´TAG-EGL-1 (lane2.9 extra cells in the anterior pharynx. This reduction in
9), S´TAG (lane 10), luciferase (lane 11), and SSN6 (lane 12). Lanescell death associated with a reduction in ced-9 activity in
13 and 14 represent 60% of GST and 40% of GST-CED-9 proteina ced-3(weak) background has beenreported previously
used per binding reaction (12% SDS-PAGE, stained with Coomassie
and has been interpreted as suggesting that ced-9 might blue).
not only have a cell death protective activity but also a (B) The interaction between CED-9 and EGL-1 depends on the BH3-
cell death promoting activity (Hengartner and Horvitz, like region of EGL-1. 35S-labeled S´TAG-EGL-1 (lanes 1 and 4),
S´TAG-EGL-1 with a deletion of the BH3-like region (S´TAG-EGL-11994a).
DBH3) (lanes 2 and 5; 13.4 kDa), or S´TAG-EGL-1 protein encoded
by the egl-1(n1084 n3082) allele (which causes a frameshift andEGL-1 and CED-9 Physically Interact
premature termination) (S´TAG-EGL-1 trunc) (lanes 3 and 6; 11.2
The mammalian BH3-containing proteins Bik, Bid, Hara- kDa) were incubated with GST-CED-9 (lanes 1±3) or GST alone (lanes
kiri, and Bad physically interact with members of the 4±6) and analyzed for binding. Lanes 7±9 represent 10% of the input
Bcl-2 family of proteins (Boyd et al., 1995; Yang et al., of S´TAG-EGL-1 (lane 7), S´TAG-EGL-1 DBH3 (lane 8), or S´TAG-
EGL-1 trunc (lane 9). Forty percent of the GST-CED-9 and GST1995; Han et al., 1996a; Wang et al., 1996; Inohara et
proteins are shown in lanes 10 and 11 (15% SDS-PAGE, stainedal., 1997; Kelekar et al., 1997; Ottilie et al., 1997b; Zha
with Coomassie blue).et al., 1997). To determine whether the EGL-1 and CED-9
proteins can directly bind to each other, we first used
a yeast two-hybrid system based on the DNA-binding
then reisolated and analyzed for associated 35S-S´TAG-and transactivation domain of the yeast GAL4 protein
EGL-1 by SDS-PAGE and autoradiography. As shown(Bai and Elledge, 1996). Clones transformed with either
in Figure 3A, GST-CED-9 interacted with S´TAG-EGL-1the EGL-1-GAL4 transactivation fusion or the CED-9-
but not with any of the control proteins tested, suchGAL4 DNA-binding domain fusion alone did not turn
as S´TAG alone, luciferase, or the yeast protein SSN6.blue even after extended periods of incubation using
Furthermore, incubation of GSTalone with S´TAG-EGL-1a b-galactosidase±filter assay and had no detectable
did not result in binding, indicating that the observedb-galactosidase activity when measured more quantita-
binding is specific for the CED-9 and EGL-1 proteins.tively in liquid (0.2 6 0.2 and 0.1 6 0.1 units/OD600 6
The BH3 domain is involved in the binding of BH3-standard deviations, respectively). By contrast, clones
containing proteins to members of the Bcl-2 family oftransformed with both fusions turned blue in fewer than
proteins (Han et al., 1996b; Wang et al., 1996; Inohara30 min and had 32.0 6 2.7 units of b-galactosidase
et al., 1997; Kelekar et al., 1997; Ottilie et al., 1997b; Zhaactivity/OD600, suggesting that the EGL-1 protein and
et al., 1997). To analyze the role of the BH3-like regionthe CED-9 protein interacted in this system. We con-
of EGL-1 in the interaction between EGL-1 and CED-9,firmed this result by examining the interaction of these
we tested mutant EGL-1 proteins in the in vitro bindingtwo proteins in vitro. Glutathione S-transferase (GST)±
assay. EGL-1 protein that lacks the nine residues similartagged CED-9 (GST-CED-9) or GST alone was affinity
to the BH3 domain of Bcl-2±like and BH3-containingpurified and incubated with in vitro transcribed and
proteins (S´TAG-EGL-1 DBH3) had a reduced abilitytranslated 35S-methionine±labeled tagged EGL-1 pro-
tein (35S-S´TAG-EGL-1). GST-CED-9 or GST alone was to bind to GST-CED-9 (Figure 3B). The interaction of
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S´TAG-EGL-1 with GST-CED-9 was completely elimi- is a poor target for EMS or that the egl-1 null phenotype
is not simply a block in cell death but includes othernated by the introduction into the EGL-1 protein of the
egl-1(lf) mutation n3082 (S´TAG-EGL-1 trunc), which, as defects, such as embryonic lethality.
described above, is a 5 bp deletion predicted to result
in the formation of a truncated EGL-1 protein lacking egl-1 Might Integrate Cell Death±Inducing Signals
the putative BH3 domain and the C terminus of the The egl-1 gene is the earliest acting component of the
protein. These results suggest that the BH3-like region central cell death machinery identified in C. elegans so
of EGL-1 is required for efficient binding of EGL-1 to far. egl-1 functions upstream of ced-9, ced-4, and ced-3
CED-9. and downstream of or in parallel to ces-2 and ces-1, two
C. elegans genes thought to be involved in specifyingthe
cell death fate of a subset of cells, such as the sisterDiscussion
cells of the pharyngeal NSM neurons (Figure 4A). It is
possible that egl-1 is a direct target of ces-1 and/or ofWhy Were egl-1(lf) Alleles Not Identified Previously?
ces-2, which encodes a protein with a bZIP (basic re-By isolating a lf mutation in egl-1, we have identified a
gion/leucine zipper) DNA-binding domain similar to thatfourth component of the central cell death machinery in
of the human hepatic leukemia factor (HLF) (MetzsteinC. elegans. Previous screens that could have identified
et al., 1996). gf mutations in egl-1 lead to the deaths ofmutants with a general cell death block like that of egl-1
the HSN neurons, which are required for egg laying and(n1084 n3082) yielded a gf mutation in ced-9 and numer-
which normally survive in hermaphrodites but undergoous lf mutations in ced-3 and ced-4 but no lf mutation
programmed cell death in males (Sulston and Horvitz,in egl-1 (Ellis and Horvitz, 1986; Hengartner et al., 1992;
1977; Sulston et al., 1983). This phenotype might beHorvitz et al., unpublished observations). The previous
caused by a defect in the regulation of egl-1 activity byfailure to isolate such mutations might be explained in
a ces-1± or ces-2±like factor that normally specifies thea number of ways.
sexually dimorphic life-versus-death fate of the HSNs.egl-1 is only about one-fifth the size of the average
The egl-1 gene thus appears to act at the point of theC. elegans gene and hence provides a small target.
cell death pathway at which signals that determine theNonetheless, a large number of EMS-mutagenized hap-
cell death fate in C. elegans are integrated to specifyloid genomes have been screened (we examined at least
which cells activate the process of programmed cell45,000 such genomes; our unpublished results), and
death.given that the average gene mutates to lf at a frequency
of about 1 per 2,000 EMS-mutagenized haploid ge-
nomes (reviewed by Anderson, 1995), egl-1 target size EGL-1 May Act by Antagonizing CED-9
EGL-1 might be a new member of the BH3 only±con-alone seems unlikely to be responsible. Perhaps the
small egl-1 gene contains no sites readily mutable by taining group of cell death activators, which includes
Bik, Bid, Harakiri, and Bad (Boyd et al., 1995; Yang etEMS, which predominantly induces GC-to-AT transition
mutations and mutates different GC base pairs at very al., 1995; Han et al., 1996a; Wang et al., 1996; Inohara
et al., 1997; Kelekar et al., 1997; Ottilie et al., 1997b; Zhadifferent frequencies (Coulondre and Miller, 1977).
Alternatively, as described above, the n3082 mutation et al., 1997). Various models have been proposed for
how BH3 only±containing cell death activators inducemight not be a null mutation, and an egl-1 null mutation
might cause a phenotype in addition to the block in cell death. In the cases of Bik, Harakiri, and Bad, for
example, all of which bind to Bcl-2±like cell death inhibi-programmed cell death, such as embryonic lethality.
The screens performed previously for mutants with a tors, deletions of, or mutations within the BH3 domains
reduce or eliminate both their abilities to bind to Bcl-general cell death block would not have identified invia-
ble cell death defective mutants. It is also conceivable 2±like cell death inhibitors and to induce cell death (Chit-
tenden et al., 1995; Han et al., 1996a; Inohara et al.,that n1084 n3082 is an altered-function (neomorphic)
allele and results in an egl-1 gf phenotype such that the 1997; Kelekar et al., 1997; Zha et al., 1997). This result
suggests that Bik, Harakiri, and Bad induce death bynovel mutant EGL-1 protein interferes with the pathway
for programmed cell death. This possiblity seems un- binding to and blocking Bcl-2±like cell death inhibitors.
The situation appears different in the case of Bid, whichlikely for three reasons: gene-dosage experiments sug-
gest that n1084 n3082 is an lf allele; deficiencies that binds to both the cell death inhibitor Bcl-2 and to the
cell death activator Bax (Wang et al., 1996). Analysis ofspan egl-1 when homozygous lead to a block in cell
death; and the ectopic expression of wild-type egl-1 the BH3 domain of Bid resulted in the identification of
mutations that block the ability of Bid to bind to Bcl-2can induce cell death.
Another possibility is that the egl-1(n1084 n3082) chro- but do not affect its capacity to bind to Bax and to
induce cell death, and vice versa. These data favor amosome contains an additional mutation that in combi-
nation with this egl-1 allele prevents programmed cell model in which a Bid/Bax heterodimer is the functional
cell death effector, which might be antagonized by thedeath. If so, based upon our analyses of the phenotype
of egl-1(n1084 n3082)/deficiency heterozygotes, this cell death inhibitor Bcl-2.
How might EGL-1 function to engage the cell deathsecond gene would have to be located within a region
of less than 0.5 map units on the genetic map and about machinery and cause cell death in C. elegans? Our data
indicate that EGL-1 requires the activities of CED-4 and1 Mb on the physical map (our unpublished observa-
tions). of the caspase CED-3 to trigger cell death and that
EGL-1 acts through the Bcl-2±like protein CED-9 (FigureWe prefer the possibilities that either the egl-1 gene
Cell
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Figure 4. The Function ofegl-1 in Programmed
Cell Death in C. elegans
(A) The genetic pathway for programmed cell
death in C. elegans. egl-1 appears to act be-
tween the cell death specification gene ces-1
and the anti±cell death gene ced-9.
(B) Molecular model for the role of EGL-1
in initiating programmed cell death. EGL-1
displaces CED-4 from the membrane-bound
cell death inhibitor CED-9, thereby allowing
CED-4 to trigger downstream events required
for the killing process.
4A). It has been suggested that CED-9 and CED-4 exist of the Bcl-2 family can be disrupted by the presence of
BH3-containing cell death±activating proteins or pep-in a membrane-associated complex and that the associ-
ation of CED-9 with CED-4 in this complex prevents tides is indicated by the observation that the interaction
between Bcl-xL and CED-4 in vitro can be blocked byCED-4 from activating the caspase CED-3 and initiating
programmed cell death (reviewed by Jacobson, 1997; Bax, Bak, Bik, or a Bak-derived BH3 peptide (Chinnaiyan
et al., 1997a; Ottilie et al., 1997a).Vaux, 1997). We propose that EGL-1 triggers cell death
by binding to CED-9. This interaction might result in the Our studies demonstrate that EGL-1 plays a major
role in controlling programmed cell death in C. elegansdisplacement of CED-4 from a membrane-associated
complex, thereby allowing CED-4 to initiate cell death by acting as a negative regulator of the Bcl-2±like cell
death inhibitor CED-9. Although we believe that EGL-1(Figure 4B). EGL-1 might therefore act to antagonize the
ability of CED-9 to block CED-4. induces cell death by displacing CED-4 from CED-9,
this model may be an oversimplification, since additionalThis model is based on the following observations.
First, EGL-1 interacts with CED-9, both in a two-hybrid Bcl-2±like molecules might exist in C. elegans, an anti-
apoptotic isoform of CED-4, called CED-4L, has beensystem and in vitro. This interaction is abolished by the
egl-1(lf) mutation n3082, which causes a Ced phenotype described (Shaham and Horvitz, 1996b), and CED-9 can
act as a substrate for the CED-3 caspase (Xue and Hor-in vivo. These observations are consistent with the hy-
pothesis that the ability of EGL-1 to bind to CED-9 is vitz, 1997). These considerations indicate that the con-
trol of programmed cell death in C. elegans may wellrequired for the ability of EGL-1 to induce killing in vivo.
Second, it seems likely that CED-9 cannot bind to EGL-1 be more complex.
and CED-4 simultaneously. The BH1, BH2, and BH3
Experimental Proceduresdomains of Bcl-2 are required for Bcl-2 to interact with
Bax (Yin et al., 1994; Hunter et al., 1996; Zha et al., 1996;
General Methods and StrainsDiaz et al., 1997), Bak (Chittenden et al., 1995), and
C. elegans strains were maintained as described by Brenner (1974).
Bad (Zha et al, 1997), and the BH1, BH2, and BH3 do- The wild-type strain generally used was N2 (Bristol). The wild-type
mains of Bcl-xL arenecessary for the interaction of Bcl-xL strain RW7000 (Bergerac) was used in conjunction with N2 for RFLP
analysis. Mutations used in this study are listed below and arewith Bak (Chittenden et al., 1995) and Bad (Kelekar et
described by Riddle et al. (1997), except where noted otherwise.al., 1997). Furthermore, when complexed with a Bak-
LGI: ced-1(e1735), ces-1(n703 n1434) (Ellis and Horvitz, 1991). LGIII:derived BH3 peptide, the BH1, BH2, and BH3 domains
ced-4(n1162), ced-9(n1950), ced-9(n2812) (Shaham and Horvitz,of Bcl-xL form an elongated hydrophobic pocket, which 1996b). LGIV: ced-3(n717); ced-3(n2427) (M. O. Hengartner and
acts like a receptor that binds the Bak BH3 domain as H. R. H., unpublished results). LGV: unc-42(e270), rol-4(sc8), egl-
a ligand (Muchmore et al., 1996; Sattler et al., 1997). 1(n1084), egl-1(n1084 n3082) (this study), unc-76(e911). Deficiencies
used were as follows: nDf42 (M. O. Hengartner and H. R. H., unpub-Considering the overall sequence similarities among
lished results), yDf8 and yDf11 (DeLong et al., 1993), itDf2 (K.Bcl-2, Bcl-xL, and CED-9 and the fact that EGL-1 con-
Kemphues, personal communication), zuDf2 (Zhu et al., 1997), andtains a region similar to the BH3 domains of Bax, Bak,
lwDf3 (M. Moseley and J. Shaw, personal communication). Alleleand Bad, it seems likely that the interaction between
designations for the integrated lines are as follows: Pmec-7 egl-1A is
CED-9 and EGL-1 is mediated by the BH1, BH2, and BH3 nIs94; Pmec-7 egl-1B is nIs95; and Pmec-7 egl-1C is nIs91.
domains of CED-9. The sequence requirement of CED-9
for its interaction with CED-4 has recently been analyzed Mapping of egl-1(n1084 n3082)
Standard genetic techniques were used to map egl-1(n1084 n3082)using two-hybrid analysis (Ottilie et al., 1997a), and the
to LGV between rol-4 and unc-76 (Brenner, 1974; Williams et al.,results suggest that all four BH domains of CED-9 are
1992). Various cosmids in the rol-4 to unc-76 interval were testednecessary for CED-9 to bind efficiently to CED-4. To-
for their abilities to detect RFLPs between N2 and RW7000. Cosmid
gether, these observations suggest that the CED-9± T20C8 was found to detect a RFLP that we named nP88 (EcoRI
binding sites for EGL-1 and CED-4 might be largely digest) (our unpublished result). The position of n1084 n3082 with
respect to nP88 and stP6 was determined as described by Ruvkunoverlapping. That CED-4 binding to cell death inhibitors
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et al. (1989). Briefly, recombinants for LGV between N2 and RW7000 1990). The sequences of all constructs generated by PCR amplifica-
tion used throughout this study were confirmed by DNA sequencing.were obtained by screening the progeny of rol-4(sc8) egl-1(n1084
n3082) unc-76(e911) (N2)/1 (RW7000) animals for Rol non-Unc and Wild-type and mutant egl-1 cDNAs were cloned into vector pCITE-
4a(1) (Novagen) such that the resulting fusion protein was taggedUnc non-Rol animals. Homozygous recombinants were scored for
n1084 n3082, nP88, and stP6. with the S´TAG (Novagen) and transcribed and translated in vitro in
the presence of 35S-methionine using a T7-based coupled reticulo-
cyte lysate (TNT Coupled Reticulocyte Lysate System, Promega).Transgenic Animals
For GST-CED-9, the ced-9 cDNA was cloned into vector pGEX-Germline transformation experiments were performed as described
4T-3 (Pharmacia), expressed in BL21(DE3) cells, and purified usingby Mello and Fire (1995). For egl-1(n1084 n3082) rescue with geno-
glutathione sepharose as suggested by the manufacturer (Phar-mic DNA, we injected ced-1(e1735); egl-1(n1084 n3082) unc-
macia). 35S-labeled S´TAG-EGL-1 and purified GST-CED-9 were in-76(e911) animals with genomic DNA contained in cosmids or
cubated for 30±60 min at 48C in 500 ml binding buffer (142.5 mMplasmids (1±10 mg/ml) and the coinjection marker p76-16B, which
KCl, 10 mM HEPES [pH 7.6], 5 mM MgCl2, 1 mM EDTA, 0.25%rescues unc-76 (50 mg/ml) (Bloom and Horvitz, 1997). Non-Unc
IGEPAL CA-630/Sigma, 2.5 mg/ml BSA). Protein complexes weretransgenic F1 animals were identified and lines established. For egl-
washed 33 with 1 ml binding buffer, 13 with 1 ml binding buffer1(n1084 n3082) rescue with the egl-1 cDNA under the control of the
without BSA, resuspended in 25 ml of 23 sample buffer, and ana-C. elegans heat-shock promoters (Phsp), we injected ced-1(e1735);
lyzed by SDS-PAGE (15%) and autoradiography.egl-1(n1084 n3082) unc-76(e911) animals with the 276 bp cDNA
transcriptionally fused to Phsp in the vectors pPD49.78 and pPD49.83
Acknowledgments(50 mg/ml) (Mello and Fire, 1995). For ectopic expression of the egl-1
cDNA in the touch cells, the same cDNA was transcriptionally fused
We thank M. Alkema, C. Bruel, F. Chen, T. Herman, B. Hersh, X. Lu,to the C. elegans mec-7 promoter (Pmec-7) contained in pPD52.102
M. Metzstein, and Z. Zhou for helpful comments and discussionsand injected into unc-76(e911) animals (50 mg/ml). Extrachromo-
concerning this manuscript. We thank M. Hengartner for providingsomal arrays carrying the Pmec-7 egl-1 fusion andthe p76-16B coinjec-
nDf42, K. Kemphues for itDf2, J. Priess for zuDf2, and M. Moseleytion marker were integrated into the genome by irradiating
and J. Shaw for lwDf3. We are grateful to J. Rothman and M. La-transgenic animals with g-rays or UV.
bouesse for sharingunpublished information. We also thank A. Coul-
son for cosmids, P. Okkema for providing the embryonic cDNA-Molecular Analysis
library, B. James for sequence determinations, M. Metzstein forStandard molecular biology protocols were used as described by
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